Humana INC Form 4 insider transactions

NYSE
Humana Director Gordon Smith acquired additional restricted stock units through compensation deferrals and dividend reinvestment, increasing his beneficial ownership.
NYSE
Humana Inc. Director Raquel C. Bono acquired additional restricted stock units through annual fees and dividend reinvestment, increasing her beneficial ownership.
NYSE
Humana's Chief Human Resources Officer, Michelle A. O'Hara, reported the acquisition of 2,353 common shares and the disposition of 1,093 shares for tax purposes on January 1, 2026.
NYSE
Humana's Chief Financial Officer, Celeste Mellet, reported the acquisition of shares and subsequent disposition for tax purposes related to stock vesting.
NYSE
Humana's Chief Information Officer, Japan Mehta, reported the acquisition of 1,194 shares and the disposition of 470 shares for tax purposes on December 15, 2025.
NYSE
Humana's President of Enterprise Growth, David Dintenfass, reported the acquisition of 2,032 common shares and the disposal of 918 shares for tax liability on vested restricted stock units.
NYSE
Humana's President of CenterWell, Sanjay K. Shetty, reported the acquisition and disposal of common stock related to equity awards and tax obligations.
NYSE
Humana's Chief Human Resources Officer, Michelle A. O'Hara, reported the acquisition of 1,401 common shares and the disposition of 632 shares for tax liability.
NYSE
Humana Inc. President & CEO James A. Rechtin reported routine stock acquisitions and dispositions related to equity awards and tax obligations.
NYSE
Humana's Chief Legal Officer, Joseph C. Ventura, reported the acquisition and disposition of common stock and the exercise of restricted stock units on December 15, 2025.
NYSE
Humana's President of Insurance, George Renaudin II, reported recent acquisitions and dispositions of company stock related to RSU vesting and tax obligations.
NYSE
Humana's SVP, Chief Accounting Officer & Controller, John-Paul W. Felter, reported the vesting of restricted stock units and subsequent sale of shares for tax obligations on December 15, 2025.
NYSE
Humana Inc. Director Gordon Smith reported the acquisition of 765 common shares and holds additional deferred restricted stock units.
NYSE
Humana's President of Insurance, George Renaudin II, reported the vesting of restricted stock units and subsequent share disposition for tax obligations, alongside updates to his equity holdings.
NYSE
Humana Director David T. Feinberg acquired 69 restricted stock units and holds a total of 2,689 shares and RSUs, reflecting deferred compensation and reinvested dividends.
NYSE
Humana Director Kurt J. Hilzinger increased his beneficial ownership of the company's equity through the acquisition of additional restricted stock units.
NYSE
Humana Director Gordon Smith acquired additional restricted stock units by converting a cash fee, aligning his interests with shareholders.
NYSE
Humana's SVP, Chief Accounting Officer, John-Paul W. Felter, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities.
NYSE
Humana Inc. Director Kurt J. Hilzinger reported an increase in his beneficial ownership of company stock units through the conversion of a cash fee into restricted stock units.
NYSE
Humana Inc. Director Gordon Smith has increased his beneficial ownership by acquiring 136 restricted stock units through a conversion of cash fees, aligning his interests with shareholders.
NYSE
Humana Inc. Director David T. Feinberg reported an increase in his beneficial ownership of company stock through the acquisition of restricted stock units as part of his compensation and dividend reinvestment.
NYSE
James A. Rechtin, President & CEO of Humana Inc., reports the purchase of 6,530 shares of Humana common stock at an average price of $229.2471.
NYSE
Director Gordon Smith reports acquisition of Humana restricted stock units through director's fees and stock incentive plan.
NYSE
Director Kurt J. Hilzinger reports the acquisition of additional Humana stock units through deferred fees and dividend reinvestments.
NYSE
Director David T. Feinberg reports acquisition of Humana stock units through deferred fees and dividend reinvestment.
NYSE
Humana Inc. executive George Renaudin II reports transactions involving company stock, including acquisitions of phantom stock units and holdings in retirement savings plans.
NYSE
Humana's Chief Information Officer, Japan Mehta, reports acquiring 3,582 restricted stock units, bringing his total holdings to 8,628 units.
NYSE
Sanjay K. Shetty, President of CenterWell at Humana Inc., reports acquiring 4,205 shares of Humana common stock and holding derivative securities including options and restricted stock units.
NYSE
Chief Human Resources Officer of Humana Inc., Michelle A. O'Hara, reports acquiring 4,205 shares of Humana common stock.
NYSE
James A. Rechtin, President & CEO of Humana Inc., reports the acquisition of shares and holdings of derivative securities in a recent Form 4 filing with the SEC.